Human Cardiosphere-Derived Cells From Advanced Heart Failure Patients Exhibit Augmented Functional Potency in Myocardial Repair

JACC: Heart Failure

Volumn 2, Issue 1, 2014, Pages 49-61

  Cheng, Ke ^a   Malliaras, Konstantinos ^a   Smith, Rachel Ruckdeschel ^a,b   Shen, Deliang ^a,c   Sun, Baiming ^a   Blusztajn, Agnieszka ^b   Xie, Yucai ^a   Ibrahim, Ahmed ^a   Aminzadeh, Mohammad Amin ^a   Liu, Weixin ^a   Li, Tao Sheng ^a,d   De Robertis, Michele A ^a   Marbán, Linda ^a,b   Czer, Lawrence S C ^a   Trento, Alfredo ^a   Marbán, Eduardo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Capricor Inc   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Cardiosphere derived cells; Heart failure; Myocardial infarction; Patient characteristics; Stromal cell derived factor 1

Indexed keywords

STROMAL CELL DERIVED FACTOR 1; SIGNAL PEPTIDE;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; BIOPSY TECHNIQUE; CARDIOMYOPATHY; CARDIOSPHERE DERIVED CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; ENGRAFTMENT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; STEM CELL; ANIMAL; AUTOTRANSPLANTATION; EXTRACELLULAR MATRIX; GRAFT SURVIVAL; HEART; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; SCID MOUSE; STEM CELL TRANSPLANTATION; CELL MIGRATION; CELL STRUCTURE; CELL THERAPY; CLINICAL ARTICLE; DISEASE SEVERITY; HEART VENTRICLE FAILURE; REGENERATIVE ABILITY;

ADULT; AGED; ANIMALS; CARDIOMYOPATHIES; EXTRACELLULAR MATRIX; FEMALE; GRAFT SURVIVAL; HEART; HEART FAILURE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE, SCID; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84892963034     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.08.008     Document Type: Article

References (51)

1. Makkar R.R., Smith R.R., Cheng K., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (caduceus): a prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
2. White A.J., Smith R.R., Matsushita S., et al. Intrinsic cardiac origin of human cardiosphere-derived cells. Eur Heart J 2013, 34:68-75.
3. Li T.S., Cheng K., Malliaras K., et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 2012, 59:942-953.
4. Smith R.R., Barile L., Cho H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908.
5. Cheng K., Shen D., Smith J., et al. Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction. Biomaterials 2012, 33:2872-2879.
6. Malliaras K., Li T.S., Luthringer D., et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 2012, 125:100-112.
7. Terrovitis J., Lautamaki R., Bonios M., et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 2009, 54:1619-1626.
8. Terrovitis J.V., Smith R.R., Marban E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106:479-494.
9. Chimenti I., Smith R.R., Li T.S., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010, 106:971-980.
10. Cheng K., Li T.S., Malliaras K., Davis D.R., Zhang Y., Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106:1570-1581.
11. Cheng K., Malliaras K., Li T.S., et al. Magnetic enhancement of cell retention, engraftment and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant 2012, 21:1121-1135.
12. Malliaras K., Zhang Y., Seinfeld J., et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med 2012, 5:191-209.
13. Davis D.R., Kizana E., Terrovitis J., et al. Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. J Mol Cell Cardiol 2010, 49. 312-1.
14. Davis D.R., Zhang Y., Smith R.R., et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS ONE 2009, 4:e7195.
15. Johnston P.V., Sasano T., Mills K., et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120:1075-1083.
16. Lee S.T., White A.J., Matsushita S., et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol 2011, 57:455-465.
17. Li T.S., Cheng K., Lee S.T., et al. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells 2010, 28:2088-2098.
18. Shen D., Cheng K., Marban E. Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J Cell Mol Med 2012, 16:2112-2116.
19. Loffredo F.S., Steinhauser M.L., Gannon J., Lee R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011, 8:389-398.
20. Tang X.L., Rokosh G., Sanganalmath S.K., et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010, 121:293-305.
21. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001, 104:1046-1052.
22. Bergmann O., Bhardwaj R.D., Bernard S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
23. Kajstura J., Gurusamy N., Ogórek B., et al. Myocyte turnover in the aging human heart. Circ Res 2010, 107:1374-1386.
24. D'Amario D., Fiorini C., Campbell P.M., et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 2011, 108:857-861.
25. Mishra R., Vijayan K., Colletti E.J., et al. Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation 2011, 123:364-373.
26. Rupp S., Bauer J., von Gerlach S., et al. Pressure overload leads to an increase of cardiac resident stem cells. Basic Res Cardiol 2012, 107:1-7.
27. Kubo H., Jaleel N., Kumarapeli A., et al. Increased cardiac myocyte progenitors in failing human hearts. Circulation 2008, 118:649-657.
28. Fortini C., Toffoletto B., Fucili A., et al. Circulating stem cell vary with nyha stage in heart failure patients. J Cell Mol Med 2011, 15:1726-1736.
29. Theiss H.D., David R., Engelmann M.G., et al. Circulation of cd34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J 2007, 28:1258-1264.
30. Frangogiannis N.G. The stromal cell-derived factor-1/CXCR4 axis in cardiac injury and repair. J Am Coll Cardiol 2011, 58:2424-2426.
31. Ghadge S.K., Mühlstedt S., Özcelik C., Bader M. Sdf-1α as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther 2011, 129:97-108.
32. Hu X., Dai S., Wu W.-J., et al. Stromal cell-derived factor-1α confers protection against myocardial ischemia/reperfusion injury. Circulation 2007, 116:654-663.
33. Saxena A., Fish J.E., White M.D., et al. Stromal cell-derived factor-1α is cardioprotective after myocardial infarction. Circulation 2008, 117:2224-2231.
34. Segers V.F.M., Tokunou T., Higgins L.J., MacGillivray C., Gannon J., Lee R.T. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007, 116:1683-1692.
35. Askari A.T., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
36. Deshane J., Chen S., Caballero S., et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 2007, 204:605-618.
37. Kanda S., Mochizuki Y., Kanetake H. Stromal cell-derived factor-1α induces tube-like structure formation of endothelial cells through phosphoinositide 3-kinase. J Biol Chem 2003, 278:257-262.
38. Petit I., Jin D., Rafii S. The SDF-1 CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007, 28:299-307.
39. Guo Y., Hangoc G., Bian H., Pelus L.M., Broxmeyer H.E. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells 2005, 23:1324-1332.
40. Huang C., Gu H., Zhang W., Manukyan M.C., Shou W., Wang M. SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial stat3 signaling following global ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol 2011, 301:H1496-H1505.
41. Jaleel M.A., Tsai A.C., Sarkar S., Freedman P.V., Rubin L.P. Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival. Mol Hum Reprod 2004, 10:901-909.
42. Kortesidis A., Zannettino A., Isenmann S., Shi S., Lapidot T., Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005, 105:3793-3801.
43. Lataillade J.-J., Clay D., Dupuy C., et al. Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 2000, 95:756-768.
44. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
45. Zakharova L., Mastroeni D., Mutlu N., et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovas Res 2010, 87:40-49.
46. Stastna M., Chimenti I., Marbán E., Van Eyk J.E. Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics 2010, 10:245-253.
47. Jiang L., Huang Y., Hunyor S., dos Remedios C.G. Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle. Eur Heart J 2003, 24:742-751.
48. Grieve D.J., Shah A.M. Oxidative stress in heart failure. Eur Heart J 2003, 24:2161-2163.
49. Penn M.S., Pastore J., Miller T., Aras R. SDF-1 in myocardial repair. Gene Ther 2012, 19:583-587.
50. Penn M.S. Importance of the SDF-1:CXCR4 axis in myocardial repair. Circ Res 2009, 104:1133-1135.
51. Zaragoza C., Gomez-Guerrero C., Martin-Ventura J.L., et al. Animal models of cardiovascular diseases. J Biomed Biotech 2011, 2011:497841.